Anika Therapeutics (ANIK)

$16.07 -0.12 (-0.74%)
Market Cap 237.12M
Revenue (ttm) 166.66M
Net Income (ttm) -82.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -49.60%
Debt to Equity Ratio 0.00
Volume 64,500
Avg Vol 99,438
Day's Range N/A - N/A
Shares Out 14.65M
Stochastic %K 37%
Beta 0.90
Analysts Strong Sell
Price Target $25.00

Latest News on ANIK

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:01 PM EST - 25 days ago

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

Anika To Participate in December 2024 Investor Conferences

Nov 22, 2024, 4:16 PM EST - 2 months ago

Anika To Participate in December 2024 Investor Conferences

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Nov 2, 2024, 9:41 PM EDT - 2 months ago

Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Oct 31, 2024, 11:00 AM EDT - 2 months ago

Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics

Anika Reports Third Quarter 2024 Financial Results

Oct 31, 2024, 7:05 AM EDT - 2 months ago

Anika Reports Third Quarter 2024 Financial Results

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Oct 31, 2024, 7:00 AM EDT - 2 months ago

Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical

Anika Announces Third Quarter 2024 Results Conference Call Date

Oct 17, 2024, 4:01 PM EDT - 3 months ago

Anika Announces Third Quarter 2024 Results Conference Call Date

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 4, 2024, 4:01 PM EDT - 3 months ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:49 AM EDT - 5 months ago

Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript

Anika Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 5 months ago

Anika Reports Second Quarter 2024 Financial Results

Anika to Participate in the Sidoti Virtual Investor Conference

Aug 5, 2024, 4:01 PM EDT - 5 months ago

Anika to Participate in the Sidoti Virtual Investor Conference

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 25, 2024, 9:00 AM EDT - 6 months ago

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

Jul 11, 2024, 8:30 AM EDT - 6 months ago

Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs

Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research

Jul 1, 2024, 10:35 AM EDT - 7 months ago

Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research

Anika Enters into Cooperation Agreement with Caligan Partners

May 28, 2024, 4:05 PM EDT - 8 months ago

Anika Enters into Cooperation Agreement with Caligan Partners

Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript

May 8, 2024, 11:36 PM EDT - 9 months ago

Anika Therapeutics, Inc. (ANIK) Q1 2024 Earnings Call Transcript

Anika Announces CFO Transition

May 8, 2024, 4:08 PM EDT - 9 months ago

Anika Announces CFO Transition

Anika Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 9 months ago

Anika Reports First Quarter 2024 Financial Results

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Apr 18, 2024, 4:01 PM EDT - 9 months ago

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 2, 2024, 8:00 AM EDT - 10 months ago

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Anika Therapeutics, Inc. (ANIK) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 7:17 PM EDT - 11 months ago

Anika Therapeutics, Inc. (ANIK) Q4 2023 Earnings Call Transcript

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Mar 13, 2024, 4:05 PM EDT - 11 months ago

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

Feb 27, 2024, 4:01 PM EST - 11 months ago

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

Feb 13, 2024, 9:00 AM EST - 1 year ago

Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Nov 28, 2023, 9:00 AM EST - 1 year ago

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Anika to Participate in Upcoming Investor Conferences

Nov 7, 2023, 4:05 PM EST - 1 year ago

Anika to Participate in Upcoming Investor Conferences

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 4:34 PM EDT - 1 year ago

Anika Therapeutics, Inc. (ANIK) Q3 2023 Earnings Call Transcript

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Nov 2, 2023, 4:05 PM EDT - 1 year ago

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

Oct 10, 2023, 9:00 AM EDT - 1 year ago

Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

Sep 19, 2023, 9:00 AM EDT - 1 year ago

Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Sep 12, 2023, 9:00 AM EDT - 1 year ago

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs

Aug 17, 2023, 6:20 PM EDT - 1 year ago

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs

Anika Reports Second Quarter 2023 Financial Results

Aug 8, 2023, 4:05 PM EDT - 1 year ago

Anika Reports Second Quarter 2023 Financial Results

Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Jul 20, 2023, 4:05 PM EDT - 1 year ago

Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

Jul 12, 2023, 9:00 AM EDT - 1 year ago

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

May 30, 2023, 4:05 PM EDT - 1 year ago

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript

May 13, 2023, 12:23 PM EDT - 1 year ago

Anika Therapeutics Inc. (ANIK) Q1 2023 Earnings Call Transcript

Anika Reports First Quarter 2023 Financial Results

May 9, 2023, 4:05 PM EDT - 1 year ago

Anika Reports First Quarter 2023 Financial Results

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Apr 19, 2023, 8:30 AM EDT - 1 year ago

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Anika Enters Into Cooperation Agreement with Caligan Partners

Apr 13, 2023, 5:00 PM EDT - 1 year ago

Anika Enters Into Cooperation Agreement with Caligan Partners

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Apr 12, 2023, 9:00 AM EDT - 1 year ago

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

Apr 3, 2023, 9:00 AM EDT - 1 year ago

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

Anika Files Preliminary Proxy Statement

Mar 27, 2023, 8:55 AM EDT - 1 year ago

Anika Files Preliminary Proxy Statement

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

Mar 8, 2023, 10:00 AM EST - 2 years ago

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

Anika Therapeutics, Inc. (ANIK) Q4 2022 Earnings Call Transcript

Mar 6, 2023, 7:48 PM EST - 2 years ago

Anika Therapeutics, Inc. (ANIK) Q4 2022 Earnings Call Transcript

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

Mar 6, 2023, 4:05 PM EST - 2 years ago

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

Feb 28, 2023, 9:00 AM EST - 2 years ago

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

Feb 21, 2023, 10:30 AM EST - 2 years ago

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

Anika Issues Statement

Feb 21, 2023, 10:00 AM EST - 2 years ago

Anika Issues Statement

Caligan Partners Issues Open Letter to Anika Board

Feb 21, 2023, 8:00 AM EST - 2 years ago

Caligan Partners Issues Open Letter to Anika Board